Pulmonary function loss in diphenylhydantoin therapy.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects; D001769:Blood; D002245:Carbon Dioxide / Q000097:blood; D002648:Child; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008168:Lung / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D010100:Oxygen / Q000097:blood; D010313:Partial Pressure; D010672:Phenytoin / Q000008:administration & dosage / Q000009:adverse effects*; D005082:Physical Exertion; D011653:Pulmonary Diffusing Capacity; D012129:Respiratory Function Tests; D012146:Rest; D012640:Seizures / Q000188:drug therapy
D000927:Anticonvulsants; D002245:Carbon Dioxide; D010672:Phenytoin; D010100:Oxygen